Molecular Reality Corporation is building utility-scale molecular sensing: solid-state nanopore infrastructure that will let everyone “see” (as in count, identify, characterize, and discover) any and all molecules from around them and inside them.
"Why do this? Because, more than any other infrastructure, this will be why we "cure all diseases" this century."
YOU CAN HELP MAKE THIS HAPPEN JUST BY PLAYING A GAME!
Epic Quest Bio™ is the gamified operating system of our startup.
SIGN UP HERE TO ENROLL IN THE BETA LAUNCH.
Problem: No Utility for Molecular Reality
- Molecular data is scarce, siloed, and expensive; high-quality signals come mostly from well-resourced labs running narrow, target-specific assays.
- Existing platforms (qPCR, mass spec, ELISA, biological nanopores) are powerful but fragile, reagent-bound, and fundamentally not deployable in plumbing, HVAC, or consumer hardware at global scale.
- Solid-state nanopores are the only sensing modality with the theoretical range to see ions, small molecules, polymers, viruses, cells, and aggregates in a single architecture, but progress has been slow due to cost, tedium, and lack of coordinated parameter search.
Core Thesis
- Universal, label-free molecular identification will not be solved by a single heroic lab; it requires a Manhattan Project–scale exploration of pore materials, geometries, voltages, buffers, and analytes.
- The only tractable way to explore this combinatorial space is a distributed, standardized, solid-state platform generating massive, diverse, open datasets for machine learning models trained directly on raw ionic current time series.
- The MR1 Molecular Streaming Device plus Epic Quest Bio™ is that platform: thousands of identical instruments, coordinated, gamified experiments, and a unified data pipeline into a single Molecular World Model.
Platform: MR1 Device Specifications
Handheld, solid-state Coulter / nanopore hybrid for resistive pulse sensing over ~pA–µA current ranges.
Electronics Stack
- ESP32‑S3 MCU for control, streaming, on-device preprocessing.
- LMP7721 ultra‑low input bias current transimpedance preamp for picoampere resolution.
- MAX11169 16‑bit ADC, 10–125 kS/s effective sampling.
- MCP4822 DAC plus TL3541 op‑amps for precise bias control and fast polarity switching.
- Four-layer FR‑4 PCB with separated analog/digital domains and star-ground.
Flow-cell Architecture
- Replaceable cartridges with silicon micropores (Bosch DRIE) in first wave.
- Roadmap pores: SiN, SiO₂, Al₂O₃, HfO₂, monolayer graphene, MoS₂, h‑BN, polymers (PET, polyimide).
- Integrated Ag/AgCl electrodes with mechanical provisions for future multi-pore arrays.
Science Roadmap
Phase 1 (Current)
Micron-scale particles and cells; Coulter-counter replication, flow optimization. Parameter sweeps across pore size and voltage. Open data for early ML models.
Years 2–3
Viral-scale and protein-scale analytes. Target 0.1–10 bases/s solid-state DNA sequencing attempts. Begin multi-analyte classification via supervised/unsupervised models.
Years 4–5
Second-gen (MR2) CMOS-integrated arrays (10³–10⁶ pores/chip) with multi-modal detection. First “universal diagnostic” prototypes.
Years 5–10
Infrastructure deployment: smart toilets, sinks, and HVAC; continuous passive monitoring of human/environmental molecular flux.
Key Technical Innovations
- Mechanical nanopores: Laterally movable overlapping apertures enabling real-time mechanical control of effective pore cross-section for translocation slowdown and oversampling.
- Ping-pong translocation control: Fast voltage polarity switching to shuttle individual particles back-and-forth, enabling sub-cubic-angstrom volumetric precision.
- Galaxy-of-pores strategy: Systematic A/B testing across substrate materials, geometries, and buffers via standardized cartridges at pennies per flow cell.
- Molecular World Model: Transformers and deep RL agents trained on raw ionic current time series to optimize discriminability and throughput.
Research Methodology
The "Molecular Streaming Corps" distributes research via Epic Quest Bio™:
- Thousands of Player Scientists™ operating standardized MR1 devices.
- Experiments encoded as gamified missions (Maxine’s Quest™).
- Reward structure (XP → advisory equity) aligned to data quality, novelty (USPEs), and community contributions.
Validation: Cross-user reproducibility metrics using shared reference samples. Orthogonal benchmarking against qPCR and mass spec.
Why Solid-State (vs. Biopores)?
| Dimension |
Biological Pores (e.g. ONT) |
Solid-State (MR1 Roadmap) |
| Stability |
Fragile; temp/salt sensitive, requires cold chain. |
Robust; tolerates wide T, pH, solvents. No cold chain. |
| Integration |
Hard to co-fabricate with CMOS. |
Direct CMOS / semi-fab compatibility. |
| Range |
Specific biomolecules only. |
Ions → small molecules → cells. |
| Scale |
Unsuitable for plumbing/HVAC. |
Designed for infrastructure. |
Competitive Position
- Deep ss-nanopore experience:We pioneered new types of solid-state nanopores and Prof. George Church, one of the first inventors of nanopore sensing, invested in our mission.
- Full Stack: Integrated hardware (MR1), software, and community stack. No dependence on fragile biological components.
- Radical Openness: Open-source hardware/firmware and public domain signal data preventing IP lock-up.
- Business Model: Data, algorithms, and infrastructure rather than instrument sales.
Applications
- Near term: Coulter-style cell counting, water/wastewater monitoring, food spoilage.
- Medium term: Viral/bacterial classification, protein kinetics, microbiome profiling.
- Long term: Point-of-use plumbing diagnostics, early disease detection, longitudinal phenotyping.
Ethics & Governance
- Acknowledges privacy risks of utility-scale sensing; treats as a civilizational design problem.
- Data moves from open research (early) to privacy-preserving protocols (clinical).
- Community co-ownership via XP→equity pipeline.